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OBJECTIVE — Alterations in maternal lipid metabolism could affect fetal programming and
the susceptibility for atherosclerosis in the offspring; therefore, we studied differences in lipid
proﬁles of pregnant women with type 1 and type 2 diabetes.
RESEARCH DESIGN AND METHODS — A total of 173 diabetic pregnancies were
studied prior to conception (V0), at each trimester (V1–V3), and after delivery and were com-
pared with 137 healthy women at V3.
RESULTS — During gestation, the increase in serum lipid concentrations was less pro-
nouncedintype2diabeticsubjects.AtV3,thelipidlevelsoftype1diabeticwomenwithnormal
glucose tolerance were similar but signiﬁcantly higher then those of type 2 diabetic women.
Elevated triglycerides and low HDL cholesterol at V3 were signiﬁcant predictors for large-for-
gestational-age (LGA) newborns.
CONCLUSIONS — Our data suggest smaller changes in serum lipid concentrations during
pregnancy in type 2 diabetic mothers. Additionally, we found a positive association between
maternal triglycerides and LGA infants independently of chronic glycemic control.
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D
ecreased HDL cholesterol, elevated
triglyceride, and increased LDL
cholesterol levels are common fea-
tures of type 2 diabetes and represent im-
portant atherogenic risk factors (1). Non-
HDL cholesterol (NHDL-C) (total
cholesterol minus HDL cholesterol) com-
prises further atherogenic lipoproteins
andissuggestedtobeamorereliablepre-
dictor of cardiovascular disease (2).
Although mild forms of hyperlipid-
emia are common during normal preg-
nancy (3), subtle disturbances of the
maternal metabolic milieu could play a
key role in the newborns’ later life (4–7).
Currently, data on serum lipid levels
in pregnant women affected by different
forms of diabetes are scarcely available.
Therefore, we evaluated differences in
gestational serum lipid proﬁles of type 1
and type 2 diabetic women as well as the
associations of maternal lipid levels with
birthweight,ponderalindex,andtherisk
of delivering large-for-gestational-age
(LGA) infants.
RESEARCH DESIGN AND
METHODS— In this longitudinal
study,weconsecutivelyincluded173sin-
gleton diabetic pregnancies (109 women
with type 1 diabetes and 64 women with
type 2 diabetes) attending our diabetes
outpatient clinic between January 1995
andJanuary2006.Atotalof137pregnan-
cies with normal glucose tolerance in the
third trimester attending our outpatient
clinic between September 2007 and April
2009 served as a control group. Medical
records were used to collect data on ma-
ternal LDL cholesterol, HDL cholesterol,
NHDL-C, triglycerides, and total choles-
terol measured at baseline within 6
months prior to conception (V0), at each
trimester (V1–V3), and during the ﬁrst
14 months after delivery (V4) as well as
the biometric parameters of the new-
borns. LGA was deﬁned as birth weight
above the 90th percentile, adjusted for
sex and age of the Austrian population.
The study was approved by the local eth-
ics committee.
Statistical analysis
Univariable cross-sectional comparisons
were performed by using the Student t
test. Linear mixed-effects models were
used to evaluate the changes of lipid lev-
els, as well as to compare differences be-
tween type 1 and type 2 diabetic subjects
after confounder adjustment (maternal
age, BMI, and A1C). The identiﬁcation
number was included as a random effect,
and data of all visits were compared with
V0. BMI, A1C, and triglyceride levels
were log transformed.
AtV3,dataoftype1diabeticandtype
2 diabetic subjects and subjects with nor-
mal glucose tolerance were compared by
confounder-adjusted ANCOVA models
and contrast analyses, respectively. Pear-
son correlation was used to evaluate
whether maternal lipids in the third tri-
mester of pregnancy are predictive for
birth weight or ponderal index (kg/m
3),
and logistic regression models were used
to estimate predictors for having LGA
infants.
Statistical analysis was performed us-
ing R (version 2.9.0) and SPSS (version
13.0). A two-sided P value 0.05 was
considered statistically signiﬁcant. P val-
ues and 95% CIs of longitudinal ana-
lyses were adjusted using Bonferroni
correction.
RESULTS— Table 1 shows the charac-
teristics of the sample and cross-sectional
analysis. Univariable longitudinal analysis
revealed that LDL cholesterol, NHDL-C,
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cantly lower at V1 than at V0 and
increasedlateronduringgestation.Addi-
tionally,LDLcholesterol,NHDL-C,and
total cholesterol serum levels were sig-
niﬁcantly higher at V3 but were compa-
rable to V0 after delivery. Multivariable
analysisshowedthattheincreaseinLDL
cholesterol (B  47.6 [95% CI 9.6–85.6];
PBonf  0.007), NHDL-C (B  40.8 [4.4–
77.2]; PBonf  0.020), and total cholesterol
(B 48.9 [12.7–85.1]; PBonf 0.003) lev-
els from V0 to V3 was more pronounced in
type 1 diabetic women. Also, regarding
HDL cholesterol and log-transformed
triglyceride concentrations, we found a
signiﬁcant increase at V3. Women with
type1diabetesshowedamorepronounced
increaseinlog-transformedtriglyceridelev-
els(B0.52[0.06–0.99];PBonf0.02)up
to V3.
At V3, total cholesterol ([means 
SD] 271.3  46.5; P  0.256), LDL cho-
lesterol (156.7  39.7; P  0.128), HDL
cholesterol(78.417.8;P0.974),and
NHDL-C (192.4  41.1; P  0.431) lev-
els of women with normal glucose
tolerance were comparable to type 1
diabetic subjects but signiﬁcantly higher
than those observed in type 2 diabetic
subjects. Additionally, women with nor-
mal glucose tolerance showed lower log-
transformed triglyceride levels (5.17 
0.38) than type 1 diabetic (P  0.001)
and type 2 diabetic (P  0.001) women.
At V3, we found no correlation be-
tween lipid parameters and birth weight
or ponderal index in diabetic women.
However, our data revealed a positive as-
sociation of log-transformed triglycerides
(B1.57[95%CI0.38–2.92];P0.01)
and a negative association of HDL choles-
terol (B  0.07 [0.12 to 0.03]; P 
0.001)withLGAinfants(whichremained
signiﬁcant after adjustment for maternal
age and A1C).
CONCLUSIONS — Little is known
aboutthedynamicchangesoflipidvalues
during pregnancy, as well as the conse-
quences of maternal hyperlipidemia dur-
ing pregnancy on fetal outcome. In the
present study, we investigated the serum
lipid parameters of pregnant diabetic and
healthywomenandtheircorrelationwith
birth weight and having an LGA infant.
Most interestingly, we observed a less
pronounced increase in serum lipids of
pregnant women with type 2 diabetes.
Thiswasunexpected,asinsulinresistance
and dyslipidemia are commonly related
metabolic alterations and components of
the metabolic syndrome and type 2 dia-
betes (1). Our ﬁndings are corroborated
byanotherstudyshowinglowerLDLcho-
lesterol levels in pregnant insulin-
resistantwomenwithgestationaldiabetes
mellitus, compared with women with
normal glucose tolerance. The authors
hypothesized decreased LDL cholesterol
production and increased direct removal
oftriglyceride-enrichedVLDLcholesterol
due to insulin resistance and the effect of
hyperestrogenemia on LDL cholesterol
catabolism (8). However, the results are
contradictory (9). In part, such differ-
ences might be explained by the fact that
the serum lipid levels were measured be-
tween the 24th and the 28th week of ges-
tation in one study (9), whereas in our, as
well as in another, study (8) the greatest
differences were observed in the third
trimester.
Recently, Schaefer-Graf et al. (10)
found that maternal serum triglyceride
levels signiﬁcantly correlated with abnor-
mal fetal growth in women with gestational
diabetes mellitus. This is in agreement with
our data for women with type 1 diabetes
andfurthermoreextendedtowomenwith
type 2 diabetes.
Intrauterine conditions play a key
roleinprogrammingthesusceptibilityfor
atherosclerosis in the newborns later in
life (4–7). The relationship found be-
tween maternal C-reactive protein levels
and plasma cholesterol with the extent of
atherogenesis in childhood (5) suggests
Table 1—Characteristics of the study sample
n
(type 1 diabetes/
type 2 diabetes)
Type 1
diabetes
Type 2
diabetes P
Age (years) 109/64 30.2  5.6 35.0  5.3 0.001
BMI (kg/m
2)* 101/54 24.8  3.8 32.0  7.4 0.001
A1C (%)* 107/64 7.2  1.4 6.8  1.3 0.046
Preeclampsia 109/63 18  16.5 7  10.9 0.314
Birth weight (g) 109/64 3,276  706 3,308  826 0.789
Birth length (cm) 107/64 49.7  3.8 50.4  3.9 0.246
Ponderal index (kg/m
3) 107/64 26.9  9.2 25.3  2.7 0.187
Small for gestational age 109/64 8  7.3 7  10.9 0.417
LGA 109/64 21  19.3 17  26.6 0.263
LDL cholesterol V0 (mg/dl) 61/17 111.1  31.3 125.7  40.7 0.117
LDL cholesterol V1 (mg/dl) 77/34 96.1  28.2 97.4  22.1 0.809
LDL cholesterol V2 (mg/dl) 84/26 119.3  33.8 96.8  29.3 0.003
LDL cholesterol V3 (mg/dl) 81/24 146.0  42.3 110.7  38.4 0.001
LDL cholesterol V4 (mg/dl) 65/19 114.3  30.5 113.8  27.5 0.949
NHDL-C V0 (mg/dl) 64/16 129.5  34.8 150.9  37.2 0.032
NHDL-C V1 (mg/dl) 77/34 112.5  29.7 126.6  26.5 0.019
NHDL-C V2 (mg/dl) 84/26 148.6  37.4 144.9  32.1 0.651
NHDL-C V3 (mg/dl) 81/23 193.4  44.5 169.0  36.6 0.018
NHDL-C V4 (mg/dl) 64/19 135.2  37.7 141.3  28.5 0.517
Total cholesterol V0 (mg/dl) 67/21 195.5  36.8 202.3  39.6 0.470
Total cholesterol V1 (mg/dl) 77/38 181.0  34.0 176.2  28.6 0.459
Total cholesterol V2 (mg/dl) 84/29 229.7  43.1 200.0  39.2 0.001
Total cholesterol V3 (mg/dl) 100/53 274.8  50.3 220.5  44.5 0.001
Total cholesterol V4 (mg/dl) 71/28 204.7  39.2 200.9  34.1 0.654
HDL cholesterol V0 (mg/dl) 64/16 65.2  16.1 54.5  18.7 0.024
HDL cholesterol V1 (mg/dl) 77/34 68.2  17.2 49.2  12.6 0.001
HDL cholesterol V2 (mg/dl) 84/26 80.6  16.3 56.3  13.8 0.001
HDL cholesterol V3 (mg/dl) 81/23 74.8  16.3 62.9  10.0 0.001
HDL cholesterol V4 (mg/dl) 64/19 68.0  17.9 50.3  14.6 0.001
Log triglycerides V0 (mg/dl) 67/21 4.32  0.47 4.99  0.58 0.001
Log triglycerides V1 (mg/dl) 77/38 4.36  0.39 4.97  0.34 0.001
Log triglycerides V2 (mg/dl) 84/28 4.96  0.34 5.43  0.40 0.001
Log triglycerides V3 (mg/dl) 98/53 5.51  0.30 5.55  0.39 0.466
Log triglycerides V4 (mg/dl) 71/28 4.62  0.62 5.02  0.55 0.003
DataaremeansSD,unlessotherwiseindicated.V0,priortoconception;V1–V3,ﬁrsttothirdtrimester;V4,
after delivery. *P values are based on log-transformed data.
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inﬂammation may inﬂuence atheroscle-
rosis. Infants of mothers with type 1 dia-
betes featured increased LDL cholesterol
and C-reactive protein levels (11), while
antioxidative treatment (e.g., vitamin E
supplementation) was reported to pre-
vent fetal programming for atherosclero-
sis in animal models (7,12).
In summary, we found different
changes in gestational lipid proﬁles in
bothformsofdiabetes.Asmaternalserum
lipids were associated with the risk for
LGA infants, further investigations on the
effect of maternal metabolism on fetal
programming are urgently needed.
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